Table 1. Genes differentially expressed in antibody-treated versus untreated BT474 cell

TABLE I. Genes differentially regulated by exposure to PDGF and expression of G16Q212L: Genes that are increased with PDGF and decreased with G?16 (75 genes)

TABLE II. Genes differentially regulated by exposure to PDGF and expression of G16Q212L: Genes that are decreased with PDGF and increased with G?16 (97 genes)

TABLE 1. mRNAs of Cellular Genes Modulated 3-fold or Greater by the IE1 Protein

Table 1. Gene candidates activated by cancer-associated hypomethylation

Table 2. Upregulated genes expressed at least five-fold higher in USPC compared with NEC

Table 3. Upregulated genes expressed at least 10-fold higher in NEC compared with USPC

Table 2. Expression analysis of genes in Region 1 and Region 2 amplifications

Table 3. Top 15 up-regulated genes (fold increase)

Table 2 Set of 14 differentially expressed genes that distinguish patients based on TTR

Table 1. Genes highly differentially expressed in LAPC-9 androgen-dependent and androgen-independent tumors

Table 1 Highly expressed Casodex responsive genes in the LNCaP model. Data show fold-increase in gene expression over reference samples. Each datum point represents mean ñ SE from 3 independent experiments.

Table 2 Gene expression fold change in the LNCaP model treated with Casodex.

Table 1. Differentially expressed genes in UCB-derived MSCs

Table 2. First 50 most enriched genes in UCB-derived MSCs

Table 1. Genes overexpressed in acinar tissue adjacent to infiltrating pancreatic cancer

Table 2. Genes overexpressed in parenchyma adjacent to chronic pancreatitis and to infiltrating pancreatic cancer relative to normal pancreatic parenchyma

Supplemental Table D. The HER-2/neu gene list. The subset of genes specifically expressed by the epithelial neu-positive cells that was extracted from the tumor gene list by selecting the genes that displayed also a concordant 2 fold difference in the expression between Neu/A and Neuneg/A cells.

Supplemental Table C. ?tumor? gene list. Genes whose expression changes with tumor growth (6-26 weeks) in a mouse model of  HER-2/neu-positive breast tumors